Pharmacy intervention improves adherence to cardiovascular medication
Patients had significantly better adherence scores following community pharmacy intervention measures.
Use of preventive medication following a coronary event lowers the risk of mortality, but long-term adherence to secondary prevention therapies is poor.
Researchers, led by the UCL school of pharmacy in London, conducted a community pharmacy intervention trial for patients who had acute treatment for a coronary event. The intervention involved a 15–20 minute motivational interview in the pharmacy, or by telephone, around two weeks after discharge.
Reporting in the European Journal of Hospital Pharmacy (online, 2 February 2016), the researchers found that the 32 patients assigned to the intervention had significantly better adherence scores at both three months and six months than the 39 patients assigned to the control group (mean 7.7 vs 7.0; P=0.026 and 7.5 vs 6.1; P=0.004, respectively).
The authors conclude that larger trials should confirm whether such interventions lead to improved clinical outcomes.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200659
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£55.00Buy now